1. Home
  2. CSWC vs PLSE Comparison

CSWC vs PLSE Comparison

Compare CSWC & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capital Southwest Corporation

CSWC

Capital Southwest Corporation

HOLD

Current Price

$22.21

Market Cap

1.4B

ML Signal

HOLD

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$18.07

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSWC
PLSE
Founded
1961
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CSWC
PLSE
Price
$22.21
$18.07
Analyst Decision
Buy
Buy
Analyst Count
5
1
Target Price
$23.50
$22.00
AVG Volume (30 Days)
588.7K
497.7K
Earning Date
01-01-0001
06-01-2026
Dividend Yield
11.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.83
$912.86
Revenue Next Year
$10.26
$259.66
P/E Ratio
$12.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.47
$12.56
52 Week High
$23.84
$26.30

Technical Indicators

Market Signals
Indicator
CSWC
PLSE
Relative Strength Index (RSI) 42.11 46.32
Support Level $20.42 $13.75
Resistance Level $23.06 $18.11
Average True Range (ATR) 0.54 1.44
MACD -0.06 -0.64
Stochastic Oscillator 46.00 7.31

Price Performance

Historical Comparison
CSWC
PLSE

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: